SC6177

Asset

Inhibits PLA2G15 to restore lysosomal function.

Stage

Preclinical

Modality

Small molecule

Target

Lipid and ceramide metabolism

2

Indications

0

Trials

1

Developer

In the full profile

• Targets and what it contains2
• Owner and partners1
• Evidence for its targets2
• Competitors1
• Aging relevance1

Assets